DEVELOPMENT AND IN VITRO EVALUATION OF OSMOTICALLY CONTROLLED ORAL DRUG DELIVERY SYSTEM OF CARVEDILOL
Abstract
The aim of the current study was to design a controlled porosity osmotic pump capsule of carvedilol .The capsule contains pore-forming water-soluble additives, which after coming in contact with water, dissolve, resulting in an in situ formation of a micro porous structure. The effect of different formulation variables, namely, ratio of drug to osmogent, solubilizing agent and level of pore former, different environmental media and stirring rate on the in vitro release was studied. Cellulose acetate (CA) was used as the semi permeable membrane. It was found that drug release rate increased with the increase in amount of osmogent and solubilizing and independent of different environmental media and stirring rate. Carvedilol release was, directly proportional to the level of pore former, glycerin, in the membrane. This system was found to deliver carvedilol at a zero-order rate.
Keywords:
Osmotic systems, Carvedilol, osmogent, cellulose acetate, pore former.DOI
https://doi.org/10.25004/IJPSDR.2009.010205References
Chen BP, Chow MSS. Focus on carvedilol: a novel beta-adrenergic blocking agent for the treatment of congestive heart failure. Formulary 1997; 32: 795- 805.
Lin Y, Ho H. Investigation on the drug releasing mechanism from an asymmetric membrane coated capsule with an in situ formed delivery orifice. J Control Release 2003; 89: 57-69.
Verma RK, Krishna DM, Garg S. Formulation aspects in the development of osmotically controlled oral drug delivery systems, J Control Release 2002; 79:7–27.
Theeuwes F, Swanson D, Wong P, Bonsen P, Place V, Heimlich K, Kwan KC. Elementary osmotic pump for indomethacin. J Pharm Sci 1983; 72: 253-258.
Makhija SN, Vavia PR. Controlled porosity osmotic pump-based controlled release systems of pseudoephedrine-I. Cellulose acetate as a semipermeable membrane. J Control Release 2003; 89: 5-18.
Thombre AG, DeNoto AR, Gibbes DC. Delivery of glipizide from asymmetric membrane capsules using encapsulated excipients. J Control Release 1999; 60: 333-341.
Zentner GM, Rork GS, Himmelstein KJ, inventors. Controlled porosity osmotic pump. US patent 4 968 507. November 6, 1990.
Thombre AG, Cardinal JR, Denoto AR, Herbig SM, Smith KL. Asymmetric membrane capsules for osmotic drug delivery- I Development of a manufacturing process. J Control Release 1999; 57: 55-64.
Philip AK, Pathak K. Osmotic flow through asymmetric membrane: a means for controlled delivery of drugs with varying solubility, AAPS PharmSciTech 2006; 721-25.
Published
Abstract Display: 187 
PDF Downloads: 357 
